CID 169502193

Sildenafil metabolite m10

Structural Information

Molecular Formula
C21H28N6O5S
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCNC(C4)O)OCC)C
InChI
InChI=1S/C21H28N6O5S/c1-4-6-15-18-19(26(3)25-15)21(29)24-20(23-18)14-11-13(7-8-16(14)32-5-2)33(30,31)27-10-9-22-17(28)12-27/h7-8,11,17,22,28H,4-6,9-10,12H2,1-3H3,(H,23,24,29)
InChIKey
WDKKVIGLJAHWAC-UHFFFAOYSA-N
Compound name
5-[2-ethoxy-5-(3-hydroxypiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

476.1842 Da
Monoisotopic Mass

0.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 477.19148 216.1
[M+Na]+ 499.17342 224.9
[M-H]- 475.17692 216.4
[M+NH4]+ 494.21802 217.4
[M+K]+ 515.14736 216.7
[M+H-H2O]+ 459.18146 206.8
[M+HCOO]- 521.18240 219.5
[M+CH3COO]- 535.19805 228.6
[M+Na-2H]- 497.15887 214.1
[M]+ 476.18365 218.6
[M]- 476.18475 218.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.